Panel recommendations for CEL (WHO)/CEL, NOS (ICC)
| Disease . | Panel recommendations . |
|---|---|
| CEL (WHO)/CEL, NOS (ICC) | Given the poor prognosis of CEL/CEL, NOS and the risk of organ dysfunction, all patients should be considered for HCT at diagnosis with a prompt donor search Careful assessment of cardiac and pulmonary function is advised for transplant eligibility and then for tailoring transplant platform Given the lack of disease-modifying agents, no recommendation can be made on pretreatment strategies Transplant should not be delayed once a suitable donor is found |
| Disease . | Panel recommendations . |
|---|---|
| CEL (WHO)/CEL, NOS (ICC) | Given the poor prognosis of CEL/CEL, NOS and the risk of organ dysfunction, all patients should be considered for HCT at diagnosis with a prompt donor search Careful assessment of cardiac and pulmonary function is advised for transplant eligibility and then for tailoring transplant platform Given the lack of disease-modifying agents, no recommendation can be made on pretreatment strategies Transplant should not be delayed once a suitable donor is found |